Cargando…
CD58 acts as a tumor promotor in hepatocellular carcinoma via activating the AKT/GSK-3β/β-catenin pathway
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies worldwide because of rapid progression and high incidence of metastasis or recurrence. Accumulating evidence shows that CD58-expressing tumor cell is implicated in development of various cancers. The present study a...
Autores principales: | Wang, Chuanzheng, Cao, Fei, Cao, Jiahao, Jiao, Zhen, You, Yuting, Xiong, Yu, Zhao, Wenxiu, Wang, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422835/ https://www.ncbi.nlm.nih.gov/pubmed/37573318 http://dx.doi.org/10.1186/s12967-023-04364-4 |
Ejemplares similares
-
Girdin acts as an oncogene in gastric cancer by regulating AKT/GSK3β/β-catenin signaling
por: Wang, Yun, et al.
Publicado: (2023) -
Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β‐catenin pathways
por: Yan, De‐Yi, et al.
Publicado: (2019) -
Lectin BS‐I inhibits cell migration and invasion via AKT/GSK‐3β/β‐catenin pathway in hepatocellular carcinoma
por: Jian, Qiang, et al.
Publicado: (2017) -
UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway
por: Hu, Wei, et al.
Publicado: (2016) -
PCDH8 inhibits glioma cell proliferation by negatively regulating the AKT/GSK3β/β-catenin signaling pathway
por: Zong, Zhenkun, et al.
Publicado: (2017)